Search Results - "Bui, M.M"

Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials by Rejniak, K.A, Lloyd, M.C, Reed, D.R, Bui, M.M

“…Abstract Osteosarcoma is the most common primary bone tumor in pediatric and young adult patients. Successful treatment of osteosarcomas requires a combination…”
Get full text

Serum IL-R1a and IP-10 Cytokine/chemokine Profiling Differences in Immune Responders and Non-responders to Combination Radiation / Immunotherapy for Soft Tissue Sarcoma by Noyes, D.R, Lenox, B.C, Bui, M.M, Cheong, D, Gonzalez, R.J, Heysek, R.V, Zager, J.S, Antonia, S.J, Gabrilovich, D.I, Finkelstein, S.E

Get full text

Myeloid-derived Suppressor Cell and Regulatory T Cell Immune Monitoring of Soft Tissue Sarcoma Patients Undergoing Combination External Beam Radiation and Intratumoral Dendritic Cell Vaccination by Iclozan, C.D, Cotter, M.J, Ramakrishnan, R, Lenox, B.C, Bui, M.M, Letson, G.D, Antonia, S.J, Gabrilovich, D.I, Finkelstein, S.E

Get full text

At the Confluence of Radiation Therapy and Immunotherapy: External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neoadjuvant Treatment of High-risk Soft Tissue Sarcoma Patients by Finkelstein, S.E, Gabrilovich, D.I, Bui, M.M, Cotter, M, Cheong, D, Gonzalez, R.J, Heysek, R.V, Sondak, V.K, Letson, G.D, Antonia, S.J

Get full text

Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma by Naghavi, A.O., Costello, J., Kim, Y., Joyce, D., Ahmed, K.A., Redler, G., Yang, G.Q., Rosenberg, S.A., Bryant, J.M., Bui, M.M., Henderson-Jackson, E.B., Gonzalez, R.J., Binitie, O., Lazarides, A., Mullinax, J., Feygelman, V., Ahmed, A.F., Parikh, N., Torres-Roca, J.F., Latifi, K.

“…Soft tissue sarcomas (STS) have significant inter- and intra-tumoral heterogeneity with poor response to standard neoadjuvant radiotherapy (RT). Achieving a…”
Get full text

NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report by Wells, A.E., Mallen, A.M., Bui, M.M., Reed, D.R., Apte, S.M.

“…•<1% of cervical cancers are sarcomas.•Data on neurofibrosarcoma management is scarce.•Larotrectinib is approved for NTRK1 gene fusion tumors without acquired…”
Get full text

Small-cell tumors of the liver: A cytological study of 91 cases and a review of the literature by Khalbuss, W.E., Grigorian, S., Bui, M.M., Elhosseiny, A.

“…This study was designed to consider the cytomorphological spectrum, differential diagnosis, and the role of ancillary studies in small‐cell tumors of the…”
Get full text